{"id":"NCT04242498","sponsor":"UCB Biopharma SRL","briefTitle":"A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa","officialTitle":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2020-03-02","primaryCompletion":"2021-11-09","completion":"2022-09-28","firstPosted":"2020-01-27","resultsPosted":"2024-12-05","lastUpdate":"2025-09-03"},"enrollment":509,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Hidradenitis Suppurativa"],"interventions":[{"type":"DRUG","name":"Bimekizumab","otherNames":["UCB4940"]},{"type":"OTHER","name":"Placebo","otherNames":["PBO"]}],"arms":[{"label":"Bimekizumab dosing regimen 1","type":"EXPERIMENTAL"},{"label":"Bimekizumab dosing regimen 2","type":"EXPERIMENTAL"},{"label":"Bimekizumab dosing regimen 3","type":"EXPERIMENTAL"},{"label":"Placebo Group","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of the study is to evaluate the efficacy and safety of bimekizumab in study participants with moderate to severe hidradenitis suppurativa (HS)","primaryOutcome":{"measure":"Percentage of Participants Achieving Clinical Response as Measured by Hidradenitis Suppurativa Clinical Response 50 (HiSCR50) at Week 16","timeFrame":"Week 16","effectByArm":[{"arm":"Placebo","deltaMin":32.2,"sd":null},{"arm":"BKZ Dosing Regimen 1","deltaMin":53.8,"sd":null},{"arm":"BKZ Dosing Regimen 2","deltaMin":52,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.004"},{"comp":"OG000 vs OG002","p":"0.003"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":15},"locations":{"siteCount":91,"countries":["United States","Australia","Bulgaria","Canada","Czechia","France","Germany","Hungary","Ireland","Israel","Japan","Poland","Spain","United Kingdom"]},"refs":{"pmids":["40172122","40153232","40652434","38795716"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":74},"commonTop":["Hidradenitis","Oral candidiasis","Headache","Diarrhoea","Nasopharyngitis"]}}